drugset / Trial / NCT02278471

The SCCS Polypill Pilot Trial

NCT02278471

Phase 2 Completed 303 enrolled Vanderbilt University
RandomizedParallel-groupOpen-labelPrevention

Summary

In this study the investigators will examine the effect of the polypill on medication adherence, systolic blood pressure, and LDL cholesterol over a 12 month span.

Timeline

Start
2015-12
Primary completion
2018-06-27
Completion
2018-06-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 2.5 mg
Subject Atorvastatin Small molecule 10 mg
Subject Hydrochlorothiazide Unknown 12.5 mg
Subject Losartan Other / unclassified 25 mg